It has been proposed that inhibition of TRPV4 might be beneficial for the treatment of multiple respiratory conditions, including chronic heart failure, hypoxia-induced pulmonary hypertension, acute lung injury, chronic obstructive pulmonary disease, and cough45, 57, 58. Here, TRPV4 is linked to pulmonary hypertension.